Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members

Vaccine

Volumn 27, Issue 27, 2009, Pages 3568-3575

  Eick, Angelia A ^a   Wang, Zhong ^a   Hughes, Hayley ^b   Ford, Stephen M ^b   Tobler, Steven K ^a  

^a U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

^b Military Vaccine Agency   (United States)

Author keywords

Effectiveness; Influenza vaccine; Military

Indexed keywords

INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; LIVE VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLDIER; UNITED STATES;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; MILITARY PERSONNEL; RETROSPECTIVE STUDIES; TIME FACTORS; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 65649131238     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.088     Document Type: Article

References (49)

1. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 356 (2007) 685-696
2. Shuler C.M., Iwamoto M., Bridges C.B., Marin M., Neeman R., Gargiullo P., et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 119 (2007) e587-e595
3. Allison M.A., Daley M.F., Crane L.A., Barrow J., Beaty B.L., Allred N., et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr 149 (2006) 755-762
4. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 25 (2006) 860-869
5. Ohmit S.E., Victor J.C., Rotthoff J.R., Teich E.R., Truscon R.K., Baum L.L., et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 355 (2006) 2513-2522
6. Treanor J.J., Kotloff K., Betts R.F., Belshe R., Newman F., Iacuzio D., et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 18 (1999) 899-906
7. Ohmit S.E., Victor J.C., Teich E.R., Truscon R.K., Rotthoff J.R., Newton D.W., et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 198 (2008) 312-317
8. Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 282 (1999) 137-144
9. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 (2000) 1655-1663
10. Grabenstein J.D., Pittman P.R., Greenwood J.T., and Engler R.J. Immunization to Protect the US Armed Forces: heritage, current practice, and prospects. Epidemiol Rev 28 (2006) 3-26
11. Sencer D.J., and Millar J.D. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 12 (2006) 29-33
12. Gaydos J.C., Hodder R.A., Top Jr. F.H., Soden V.J., Allen R.G., Bartley J.D., et al. Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis 136 Suppl. S356-62 (1977)
13. Hodder R.A., Gaydos J.C., Allen R.G., Top Jr. F.H., Nowosiwsky T., and Russell P.K. Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis 136 Suppl. S369-75 (1977)
14. McNeill K.M., Vaughn B.L., Brundage M.B., Li Y., Poropatich R.K., and Gaydos J.C. Clinical presentations for influenza and influenza-like illness in young, immunized soldiers. Mil Med 170 (2005) 94-97
15. Earhart K.C., Beadle C., Miller L.K., Pruss M.W., Gray G.C., Ledbetter E.K., et al. Outbreak of influenza in highly vaccinated crew of U.S. Navy ship. Emerg Infect Dis 7 (2001) 463-465
16. Laurel V.L., De Witt C.C., Geddie Y.A., Yip M.C., Dolan D.M., Canas L.C., et al. An outbreak of influenza A caused by imported virus in the United States, July 1999. Clin Infect Dis 32 (2001) 1639-1642
17. Ksiazek T.G., Olson J.G., Irving G.S., Settle C.S., White R., and Petrusso R. An influenza outbreak due to A/USSR/77-like (H1N1) virus aboard a US Navy ship. Am J Epidemiol 112 (1980) 487-494
18. Gray G.C., Callahan J.D., Hawksworth A.W., Fisher C.A., and Gaydos J.C. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 5 (1999) 379-385
19. Department of the Army, Headquarters, United States Army Medical Command. OPERATIONS ORDER 08-67 (2008-2009 Influenza Vaccine Immunization Program), 2008 [Accessed at http://www.vaccines.mil/documents/1211flu_OPERATIONS_ORDER_08_67_2008-2009.pdf on 20 February 2009].
20. Department of the Air Force, Headquarters United States Air Force. Air Force 2008-2009 Influenza Immunization Program Guidance, 2008. [Accessed at http://www.vaccines.mil/documents/1209AF%20Influenza%20Guidance%2008-09.pdf on 20 February 2009].
21. BUMED Washington DC. Policy for the Use of Influenza Vaccine for 2008-2009, 2008. [Accessed at http://www.vaccines.mil/documents/1210BUMED_influenza_0809.pdf on 20 February 2009].
22. United States Army Medical and Material Agency. 2003-2004 Influenza Virus Vaccine (Flu)/Update/Change/Management of Influenza Vaccine; 2003. [Accessed at http://usamma.detrick.army.mil/ftp/mmqc_messages/I044001.txt on 20 February 2009].
23. United States Army Medical and Material Agency. Flumist/Influenza Vaccine/Information Bulletin; 2005. [Accessed at http://usamma.detrick.army.mil/ftp/mmqc_messages/Q051233.txt on 20 February 2009].
24. Russell K.L., Ryan M.A., Hawksworth A., Freed N.E., Irvine M., Daum L.T., et al. Effectiveness of the 2003-2004 influenza vaccine among U.S. military basic trainees: a year of suboptimal match between vaccine and circulating strain. Vaccine 23 (2005) 1981-1985
25. Strickler J.K., Hawksworth A.W., Myers C., Irvine M., Ryan M.A., and Russell K.L. Influenza vaccine effectiveness among US military basic trainees, 2005-06 season. Emerg Infect Dis 13 (2007) 617-619
26. Centers for Disease Control and Prevention. Estimates of Influenza Vaccination Target Population Sizes in 2006 and Recent Vaccine Uptake Levels; 2006. [Accessed at www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf on 20 February 2009].
27. Centers for Disease Control and Prevention. Self-reported influenza vaccination coverage trends 1989-2005 among adults by age group, risk group, race/ethnicity, health-care worker status, and pregnancy, United States, National Health Interview Survey (NHIS), 2007. [Accessed at www.cdc.gov/flu/professionals/vaccination/pdf/vaccinetrend.pdf on 20 February 2009].
28. Rubertone M.V., and Brundage J.F. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 92 (2002) 1900-1904
29. Marsden-Haug N., Foster V.B., Gould P.L., Elbert E., Wang H., and Pavlin J.A. Code-based syndromic surveillance for influenza like illness by International Classification of Diseases, Ninth revision. Emerg Infect Dis 13 (2007) 207-216
30. King Jr. J.C., Stoddard J.J., Gaglani M.J., Moore K.A., Magder L., McClure E., et al. Effectiveness of school-based influenza vaccination. N Engl J Med 355 (2006) 2523-2532
31. Centers for Disease Control and Prevention. 2005-2006 U.S. Influenza Season Summary, 2006. [Accessed at http://www.cdc.gov/flu/weekly/weeklyarchives2005-2006/05-06summary.htm on 20 February 2009].
32. Centers for Disease Control and Prevention (CDC). Weekly Report: Influenza Summary Update, Week ending May 19, 2007-Week 20, 2007. [Accessed at http://www.cdc.gov/flu/weekly/weeklyarchives2006-2007/weekly20.htm on 20 February 2009].
33. Cox N.J., and Bridges C.B. Inactivated and live attenuated influenza vaccines in young children-how do they compare?. N Engl J Med 356 (2007) 729-731
34. Sasaki S., Jaimes M.C., Holmes T.H., Dekker C.L., Mahmood K., Kemble G.W., et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81 (2007) 215-228
35. Lee M.S., Mahmood K., Adhikary L., August M.J., Cordova J., Cho I., et al. Measuring antibody responses to a live attenuated influenza vaccine in children. Pediatr Infect Dis J 23 (2004) 852-856
36. Cox R.J., Brokstad K.A., and Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59 (2004) 1-15
37. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 57 (2008) 1-60
38. Lee T., Jordan N.N., Sanchez J.L., and Gaydos J.C. Selected nonvaccine interventions to prevent infectious acute respiratory disease. Am J Prev Med 28 (2005) 305-316
39. Gray G.C., Mitchell B.S., Tueller J.E., Cross E.R., and Amundson D.E. Pneumonia hospitalizations in the US Navy and Marine Corps: rates and risk factors for 6,522 admissions, 1981-1991. Am J Epidemiol 139 (1994) 793-802
40. Brundage J.F., Gunzenhauser J.D., Longfield J.N., Rubertone M.V., Ludwig S.L., Rubin F.A., et al. Epidemiology and control of acute respiratory diseases with emphasis on group A beta-hemolytic streptococcus: a decade of U.S. Army experience. Pediatrics 97 (1996) 964-970
41. Balicer R.D., Huerta M., Levy Y., Davidovitch N., and Grotto I. Influenza outbreak control in confined settings. Emerg Infect Dis 11 (2005) 579-583
42. O'Shea M.K., Ryan M.A., Hawksworth A.W., Alsip B.J., and Gray G.C. Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment. Clin Infect Dis 41 (2005) 311-317
43. Russell K.L., Hawksworth A.W., Ryan M.A., Strickler J., Irvine M., Hansen C.J., et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 24 (2006) 2835-2842
44. Bernstein D.I., Yan L., Treanor J., Mendelman P.M., and Belshe R. Cold-Adapted, Trivalent, Influenza Vaccine Study Group. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children. Pediatr Infect Dis J 22 (2003) 28-34
45. Buonagurio D.A., O'Neill R.E., Shutyak L., D'Arco G.A., Bechert T.M., Kazachkov Y., et al. Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting. Virology 347 (2006) 296-306
46. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80 (2006) 11756-11766
47. Sasaki S., He X.S., Holmes T.H., Dekker C.L., Kemble G.W., Arvin A.M., et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS ONE 3 (2008) e2975
48. Department of Army, Headquarters. Army Regulation 40-501, 2002. Accessed at https://www.jagcnet.army.mil/JAGCNetInternet/Homepages/AC/NewJARO.nsf/(JAGCNetDocID)/C3219854E28FF5FA852571BF0063076C/$FILE/AR + 40-501 + 20020930.pdf on 20 February 2009.
49. Department of Defense, Headquarters, United States Military Entrance Processing Command. US MEPCOM Regulation No. 40-1, 2002. [Accessed at http://www.mepcom.army.mil/publications/pdf/regs/r-0040-001.pdf on 20 February 2009].